Democratic Progressive Party (DPP) Legislator Huang Sue-ying (黃淑英) urged the Department of Health (DOH) yesterday to ban international pharmaceutical companies from exporting genetic data gathered in Taiwan.
Huang told a press conference that several doctors had said there has been a substantial increase in the number of hospital-based projects proposed by international pharmaceutical companies to collect human genetic data here.
The information was usually exported to the companies’ home countries to establish the firms’ biological databases for new drug innovation or medical research, she said.
“Almost all the international pharmaceutical companies have been doing this. The phenomenon is particularly common among hospitals that do human experiments,” Huang said, without naming companies or hospitals.
Huang said the practice had become prevalent because the legislature had yet to pass any legislation regulating the collection of genetic information. The health department should bar the export of genetic information already collected until legislators can pass protective legislation.
“[We] have not even resolved the human rights controversy surrounding the nation’s Taiwan Biobank project,” Huang said, warning that the collection of samples could violate test subjects’ privacy.
The health department’s Taiwan Biobank project aims to collect blood samples from 200,000 people to be used in research into the connection between human genes and diseases such as diabetes and cardiovascular ailments.
But DPP legislators and human rights activists have expressed concerns that the data could be put to inappropriate use without written regulations and violate participants’ human rights.
Chiou Wen-tsong (邱文聰), a member of Academia Sinica’s Human Subject Research Ethics Committee, said the existing Notice of Collection and Application of Human Body Samples for Research Purposes (研究用人體檢體採集與使用注意事項) was just an administrative order and therefore did not carry the weight of a law.
He urged the health department to submit relevant legislation as soon as possible.
DOH technical specialist Lee Shu-fang (李淑芳) said the department had submitted a draft act on the management of human biological data banks to the Executive Yuan for review.
Bureau of Medical Affairs Deputy Chief Liu Li-ling (劉麗玲) urged the public to make sure they know how their genetic information would be used when giving blood or tissue samples.
Alain Robert, known as the "French Spider-Man," praised Alex Honnold as exceptionally well-prepared after the US climber completed a free solo ascent of Taipei 101 yesterday. Robert said Honnold's ascent of the 508m-tall skyscraper in just more than one-and-a-half hours without using safety ropes or equipment was a remarkable achievement. "This is my life," he said in an interview conducted in French, adding that he liked the feeling of being "on the edge of danger." The 63-year-old Frenchman climbed Taipei 101 using ropes in December 2004, taking about four hours to reach the top. On a one-to-10 scale of difficulty, Robert said Taipei 101
Nipah virus infection is to be officially listed as a category 5 notifiable infectious disease in Taiwan in March, while clinical treatment guidelines are being formulated, the Centers for Disease Control (CDC) said yesterday. With Nipah infections being reported in other countries and considering its relatively high fatality rate, the centers on Jan. 16 announced that it would be listed as a notifiable infectious disease to bolster the nation’s systematic early warning system and increase public awareness, the CDC said. Bangladesh reported four fatal cases last year in separate districts, with three linked to raw date palm sap consumption, CDC Epidemic Intelligence
US climber Alex Honnold left Taiwan this morning a day after completing a free-solo ascent of Taipei 101, a feat that drew cheers from onlookers and gained widespread international attention. Honnold yesterday scaled the 101-story skyscraper without a rope or safety harness. The climb — the highest urban free-solo ascent ever attempted — took just more than 90 minutes and was streamed live on Netflix. It was covered by major international news outlets including CNN, the New York Times, the Guardian and the Wall Street Journal. As Honnold prepared to leave Taiwan today, he attracted a crowd when he and his wife, Sanni,
Taiwanese and US defense groups are collaborating to introduce deployable, semi-autonomous manufacturing systems for drones and components in a boost to the nation’s supply chain resilience. Taiwan’s G-Tech Optroelectronics Corp subsidiary GTOC and the US’ Aerkomm Inc on Friday announced an agreement with fellow US-based Firestorm Lab to adopt the latter’s xCell, a technology featuring 3D printers fitted in 6.1m container units. The systems enable aerial platforms and parts to be produced in high volumes from dispersed nodes capable of rapid redeployment, to minimize the risk of enemy strikes and to meet field requirements, they said. Firestorm chief technology officer Ian Muceus said
RSS